Accepting new patients
Dr.
Prof Andrew Protheroe
Oncology
- 🇬🇧
- GP consultation
- Annual physical exam
- Vaccination administration
- Minor procedure (skin)
About Prof Andrew Protheroe
Professor. Andrew Protheroe is an Associate Professor of Uro-Oncology within the University of Oxford Department of Oncology at the Oxford Cancer and Haematology Centre. He is a highly experienced Consultant Medical Oncologist specialising in managing urological cancer (prostate, kidney, bladder and testicular cancer) at Oxford since 2001. He qualified from St Thomas's Hospital in London and after general medical training in London, trained in Oncology at St James's University Hospital in Leeds. His PhD was in tumour immunology and the research was based at Leeds and the National Cancer Institute in Amsterdam as an Honorary ICRF Clinical Research fellow funded by a Northern and Yorkshire research award. Professor. Protheroe specialises in managing and overseeing patients with urological cancer providing specialised expert care to patients and their families covering all aspects of chemotherapy, hormonal therapy, immunotherapy, radium 223, growth inhibitors and novel therapies; giving plentiful options to give patients as many options as possible. In addition to his other work, he is also one of the founding trustees for the urological cancer charity UCARE which supports research and awareness. He was also instrumental in setting up the kidney cancer support group (FROG), and helped to develop the prostate and bladder cancer support groups and set up initiatives to support men with testicular cancer. It is clear from Professor Protheroe's work in both clinical practice, research and charity work that he is fully invested in the clinical care of his patients but also supporting their emotional wellbeing, giving them the best overall experience in their cancer journey. Diseases, Medical Tests and Treatments • Immunotherapy • Personalised medicine for urological cancers • Gastroesophageal • Head and neck oncology • Chemotherapy • Haemato-oncology • Breast ultrasound • Prostate Cancer • Bladder Cancer • Kidney Cancer • Testicular Cancer
"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."
Credentials & verification
Medical license
Organización Médica Colegial de España (OMC) · GB
#GB-41596
Valid until 2028-12-31
Verify with issuerBoard certification
European Board of Oncology
#EB-01CD5D92
Renewal due 2034
Verify with issuerMalpractice cover
AmTrust Europe
2,000,000 EUR
Valid until 2026-12-31
No claims on file
Education & training
-
2013–2019
MD · Medicine and Surgery
UAB Barcelona (GB)
-
2019–2023
Residency · Oncology
Universidad de Navarra (GB)
Career & appointments
-
2023-09–2024-08
Junior consultant
UAB Barcelona Teaching Hospital — Oncology
Procedures & conditions
| Procedure | Code | Lifetime volume |
|---|---|---|
| GP consultation | 99213 |
2,135 |
| Annual physical exam | 99395 |
937 |
| Vaccination administration | 90471 |
1,505 |
| Minor procedure (skin) | 17110 |
1,494 |
Patient reviews
See all 1"Very thorough first visit — explained every step. Booking was easy and the staff were welcoming."
"Took time to listen and reviewed all my previous results. I would absolutely recommend."
"Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent."
Recognition & press
Awards
- Top-rated Oncology — — EuroClinics Patient Choice · 2025 regional
- Excellence in Patient Care — National Society · 2024 national
Society memberships
- WONCA Europe — Family Doctors — Member · since 2024
- national college of family doctors — Member · since 2024
- European Union of Medical Specialists (UEMS) — Member · since 2024
Your consultation, step by step
- 1 Choose a slot
- 2 Brief pre-consult form
- 3 Consultation
- 4 Follow-up note & plan
Services & pricing
New patient consultation (60m)
Follow-up consultation (30m)
Vaccination administration
Minor procedure (skin)
Insurance compatibility
For international patients
Multilingual care
Coordinator: Patient liaison · professor.andrew.protheroe@euroclinics.example. Care delivered in English.
Travel & transfer
Aftercare worldwide
Coordinated follow-up by request.
Research & publications
h-index: 8 · i10: 10
Selected publications
-
Validation of clinical scoring in Oncology
DOI: 10.2438/euroclin.2026.0 · cited by 39
-
Long-term follow-up of Oncology across GB
DOI: 10.8186/euroclin.2025.1 · cited by 109
Show full research record
Invited talks
- Practical updates in Oncology · European Annual Congress (Oncology) · Vienna · 2024
- Single-centre experience in Oncology · National Society Meeting · · 2023
Articles by Prof Andrew Protheroe
Frequently asked
01. Do you accept new patients?
Prof Andrew Protheroe is currently accepting new patients. Use the booking module to choose a slot.
02. Which languages can I be seen in?
Consultations are available in English.
03. Is the consultation in-person or online?
Most services are offered both in-clinic and via telemedicine. Each service card above marks its modalities.
04. Do you accept my insurance?
In-network with major international insurers (Allianz Worldwide, AXA Global, BUPA Global and others). Use the "Verify my insurance" button to confirm your plan.
05. What is the cancellation policy?
Free cancellation up to 24 hours before your slot. Last-minute cancellations may incur a small administrative fee.
06. How is my health data protected?
All records are stored on EU servers, field-level encrypted, and GDPR compliant. Data is never shared with third parties without your explicit consent.